Multi-drug and methicillin resistance of staphylococci from canine patients at a veterinary teaching hospital (2006-2011)

Veterinary Quarterly

Volumn 33, Issue 2, 2013, Pages 60-67

  Detwiler, Ashley ^a   Bloom, Paul ^a,b   Petersen, Annette ^a   Rosser, Edmund J ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b and Ear Clinic for Animals   (United States)

Author keywords

canine; coagulase negative staphylococci; dog; extensively drug resistant; methicillin resistance; multi drug resistance; staphylococci; Staphylococcus pseudintermedius

Indexed keywords

BETA LACTAM; CHLORAMPHENICOL; CLINDAMYCIN; DOXYCYCLINE; ENROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; MARBOFLOXACIN; OXACILLIN; RIFAMPICIN; SULFATRIMETHOPRIM; TETRACYCLINE;

ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PENICILLIN RESISTANCE; RETROSPECTIVE STUDY; SCORING SYSTEM; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PSEUDINTERMEDIUS; STAPHYLOCOCCUS SCHLEIFERI;

ANIMALIA; CANIS FAMILIARIS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS PSEUDINTERMEDIUS;

EID: 84879960924     PISSN: 01652176     EISSN: 18755941     Source Type: Journal    
DOI: 10.1080/01652176.2013.799792     Document Type: Article

References (21)

1. Beck K, Waisglass S, Dick HLN, Weese JS. 2012. Prevalence of methicillin-resistant Staphylococcus pseudintermedius from skin and carriage sites of dogs after treatment of their methicillin-resistant or methicillin-sensitive staphylococcal pyoderma. Vet Dermatol. 23: 369-375.
2. Bryan J, Frank LA, Rohrbach BW, Burgette LJ, Cain CL, Bemis DA. 2012. Treatment outcome of dogs with meticillin-resistant and meticillin-susceptible Staphylococcus pseudintermedius pyoderma. Vet Dermatol. 23: 361-368.
3. Devriese LA, Vancanneyt M, Baele M, Vaneechoutte M, De Graef E, Snauwaert C, Cleenwerck I, Dawyndt P, Swings J, Decostere A, Haesebrouck F. 2005. Staphylococcus pseudintermedius sp. nov., a coagulase-positive species from animals. Int J Syst Evol Microbiol. 55: 1569-1573.
4. Fazakerley J, Nuttall T, Sales D, Schmidt V, Carter SD, Hart CA, McEwan NA. 2009. Staphylococcal colonization of mucosal and lesional skin sites in atopic and healthy dogs. Vet Dermatol. 20: 179-184.
5. Fazakerley J, Williams N, Carter S, McEwan N, Nuttall T. 2010. Heterogeneity of Staphylococcus pseudintermedius isolates from atopic and healthy dogs. Vet Dermatol. 21: 578-585.
6. Fitzgerald RJ. 2009. The Staphylococcus intermedius group of bacterial pathogens: species re-classification, pathogenesis and emergence of methicillin resistance. Vet Dermatol. 20: 490-495.
7. Frank LA, Loeffler A. 2012. Meticillin-resistant Staphylococcus pseudintermedius: clinical challenge and treatment options. Vet Dermatol. 23: 283-291.
8. Graham-Mize CA, Rosser EJ Jr. 2004. Comparison of microbial isolates and susceptibility patterns from the external ear canal of dogs with otitis externa. J Am Anim Hosp Assoc. 40: 102-108.
9. Griffeth GC, Morris DO, Abraham JL, Shofer FS, Rankin SC. 2008. Screening for skin carriage of methicillin-resistant coagulase-positive staphylococci and Staphylococcus schleiferi in dogs with healthy and inflamed skin. Vet Dermatol. 19: 142-149.
10. Huerta B, Maldonado A, Ginel PJ, Tarradas C, Gomez-Gascon L, Astorga RJ, Luque I. 2011. Risk factors associated with the antimicrobial resistance of staphylococci in canine pyoderma. Vet Microbiol. 150: 302-308.
11. Jeffers JG. 2013. Topical therapy for drug-resistant pyoderma in small animals. Vet Clin Small Anim. 43: 41-50.
12. Jones RD, Kania SA, Rohrbach BW, Frank LA, Bemis DA. 2007. Prevalence of oxacillin- and multidrug-resistant staphylococci in clinical samples from dogs: 1,772 samples (2001-2005). J Am Vet Med Assoc. 230(2): 221-227.
13. Kadlec K, Schwarz S. 2012. Antimicrobial resistance of Staphylococcus pseudintermedius. Vet Dermatol. 23: 276-282.
14. Kania SA, Williamson NL, Frank LA, Wilkes RP, Jones RD, Bemis DA. 2004. Methicillin resistance of staphylococci isolated from the skin of dogs from pyoderma. Am J Vet Res. 65: 1265-1268.
15. Magiorakos AP, Srinivasan A, Carey RB, Carmell Y, Falagas ME, Giske CG, Harbath S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 18: 268-281.
16. Morris DO, Rook KA, Shofer FS, Rankin SC. 2006. Screening of Staphylococcus aureus, Staphylococcus intermedius, and Staphylococcal schleiferi isolates obtained from small companion animals for antimicrobial resistance: a retrospective review of 749 isolates (2003-04). Vet Dermatol. 17: 332-337.
17. Murayama N, Nagata M, Terada Y, Shibata S, Fukata T. 2010. Efficacy of a surgical scrub including 2% chlorhexidine acetate for canine superficial pyoderma. Vet Dermatol. 21: 586-592.
18. Sasaki T, Kikuchi K, Tanaka Y, Takahashi N, Kamata S, Hiramatsu K. 2007. Reclassification of phenotypically identified Staphylococcus intermedius strains. J Clin Microbiol. 45: 2770-2778.
19. Schissler JR, Hillier A, Daniels JB, Cole LK, Gebreyes WA. 2009. Evaluation of clinical laboratory standards institute interpretive criteria for methicillin-resistant Staphylococcus Pseudintermedius isolated from dogs. J Vet Diagn Invest. 21: 684-688.
20. Weese JS. 2012. Staphylococcal infections. In: Greene CE, editor. Infectious diseases of the dog and cat. 4th ed. St. Louis, MO: Elsevier; p. 340-348.
21. Weese JS, van Duijkeren E. 2010. Methicillin-resistant Staphylococcus aureus and Staphylococcus pseudintermedius in veterinary medicine. Vet Microbiol. 140: 418-429.